M-tron director receives annual stock grant
LAZAR BEL reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
LAZAR BEL reported acquisition or exercise transactions in this Form 4 filing.
M-tron Industries director Bel Lazar received an annual stock grant of 242 shares of Common Stock as a non-employee director. The shares were awarded on March 19, 2026 at a stated price of $0.00 per share, reflecting equity compensation rather than a market purchase. Following this grant, Lazar directly holds 6,845 shares of M-tron Industries common stock. This appears to be a routine equity award for board service rather than an open-market transaction.
Positive
- None.
Negative
- None.
Insights
Routine, small equity grant to a non-employee director.
Director Bel Lazar received 242 shares of M-tron Industries common stock as an annual stock grant for non-employee board service. The grant price is listed as $0.00 per share, indicating compensation rather than a market trade.
After the award, Lazar holds 6,845 common shares directly, so this grant modestly increases his equity stake. There are no derivatives or option exercises disclosed, and no indication of a trading plan or sales activity, making this a straightforward, routine compensation event.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 242 | $0.00 | $0.00 |
Footnotes (1)
- F1. Annual stock grant to non-employee director.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did MPTI director Bel Lazar report in this Form 4 filing?
Was Bel Lazar’s MPTI stock transaction a market purchase or a grant?
Does the Bel Lazar Form 4 for MPTI include any stock sales?
Is the MPTI Form 4 transaction for Bel Lazar part of routine director compensation?
Does Bel Lazar hold any MPTI derivative securities in this Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.